Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The cost of endoscopic treatment for walled-off pancreatic necrosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The sentinel acute pancreatitis event hypothesis revisited

    Research output: Contribution to journalLetterResearchpeer-review

  2. Evaluation of local instillation of antibiotics in infected walled-off pancreatic necrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pain in pancreatic ductal adenocarcinoma: A multidisciplinary, International guideline for optimized management

    Research output: Contribution to journalReviewResearchpeer-review

  1. Prophylactic pancreatic duct stenting in severe acute necrotizing pancreatitis: a prospective randomized study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Modified Marshall Score Predicts Mortality in Patients With Walled-off Pancreatic Necrosis Treated in an Intensive Care Unit

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Use of minimally invasive techniques has reduced mortality in walled-off pancreatic necrosis (WON) but may be costly. The aim of this study was to evaluate the actual costs associated with the endoscopic management of patients with WON.

METHODS: We included a retrospective cohort of WON patients treated with endoscopic, transgastric drainage and necrosectomy (ETDN) during 2013-2014. Costs were calculated for six sub-areas based on a micro-costing model. Students T-test and non-parametric analysis of variance were performed to evaluate costs in relation to disease etiology and outcome.

RESULTS: We included 58 patients (50% men, median age 57 years). The most common etiologies were gallstones (57%) and alcohol (19%). Nine patients (16%) died during admission. The median length of stay was 50 days (IQR 31 days). Eighteen patients (31%) needed treatment in our intensive care unit with a median length of stay of 16 days (IQR 31 days). The mean costs and standard deviation of costs (SD) per patient were: diagnostic imaging $2,431 ($2,301), laboratory tests $3,579 ($2,477), blood products $982 ($1,734), endoscopic treatment $3,794 ($1,777), medicine $5,440 ($6,656), and ward cost $41,260 ($35,854). The mean total cost was $57,486 ($46,739). Post-ERCP pancreatitis and mortality predicted higher costs.

CONCLUSIONS: This study sheds light on the different costs associated with endoscopic treatment of WON. As nearly three quarters of the costs are related to ward care, initiatives aimed at reducing the length of hospital stay may have a great impact on making endoscopic treatment more cost effective.

Original languageEnglish
JournalPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Volume19
Issue number6
Pages (from-to)828-833
Number of pages6
ISSN1424-3903
DOIs
Publication statusPublished - Sep 2019

Bibliographical note

Copyright © 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.

    Research areas

  • Costs, Endoscopic treatment, Walled-off necrosis

ID: 57721586